Role of serine/threonine protein phosphatase in Alzheimer's disease

NeuroSignals

Volumn 11, Issue 5, 2002, Pages 262-269

  Tian, Qing ^a   Wang, Jianzhi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

protein; Alzheimer's disease; Neurofilament; Serine threonine protein phosphatase

Indexed keywords

BINDING PROTEIN; CALMODULIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOSPORIN A; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN SERINE THREONINE KINASE; AMYLOID BETA PROTEIN; MICROTUBULE ASSOCIATED PROTEIN;

ALZHEIMER DISEASE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CYTOSKELETON; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME SUBUNIT; HUMAN; INTERMEDIATE FILAMENT; MICROTUBULE; MICROTUBULE ASSEMBLY; NERVE CELL PLASTICITY; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS REGULATION; REVIEW; ANIMAL; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROTEIN PROCESSING;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; NEURONAL PLASTICITY; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SUBSTRATE SPECIFICITY;

EID: 0036769791     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067425     Document Type: Review

References (96)

1. Selkoe DJ: The molecular pathology of Alzheimer's disease. Neuron 1991;4:487-498.
2. Grundke-Iqbal I, Iqbal K, Tung Y-C, Quinlan M, Wisniewski HM, Binder LI: Abnormal phosphorylation of the microtubule associated protein τ in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986;83:4913-4917.
3. Morrison JH, Hof PR: Life and death of neurons in the aging brain. Science 1997;17:412-419.
4. Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K: Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 1993;61:921-927.
5. Gong CX, Shaikh S, Wang JZ, Zaidi T, Grundke-Iqbal I, Iqbal K: Phosphatase activity toward abnormally phosphorylated tau: Decrease in Alzheimer disease brain. J Neurochem 1995;2:732-738.
6. Pei JJ, Gong CX, Iqbal K, Grundke-Iqbal I, Wu QL, Winblad B, Cowburn RF: Subcellular distribution of protein phosphatases and abnormally phosphorylated tau in the temporal cortex from Alzheimer's disease and control brains. J Neural Transm 1998;1:69-83.
7. Lian Q, Ladner CJ, Magnuson D, Lee JM: Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex. Exp Neurol 2001;1:158-165.
8. Cohen PT: Novel protein serine/threonine phosphatases: Variety is the spice of life. Trends Biochem Sci 1997;7:245-251.
9. Zheng LY, Wang JZ, Gong CX, Pei J-J, Zaidi T, Grundke-Iqbal I, Iqbal K: Multiple forms of phosphatases from human brain: Isolation and partial characterization of Affigel blue binding phosphatases. Neurochem Res 2000;1:107-120.
10. Zheng LY, Wang JZ, Gong CX, Pei J-J, Zaidi T, Grundke-Iqbal I, Iqbal K: Multiple forms of phosphatase from human brain: Isolation and partial characterization of Affi-Gel Blue non-binding phosphatase activities. Neurochem Res 2001;4:425-438.
11. Cohen P: The structure and regulation of protein phosphatases. Annu Rev Biochem 1989;58:453-508.
12. Wang JZ, Gong CX, Zaidi T, Grundke-Iqbal I, Iqbal K: Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J Biol Chem 1995;9:4854-4860.
13. Wang JZ, Grundke-Iqbal I, Iqbal K: Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1. Brain Res Mol Brain Res 1996;2:200-208.
14. Gong CX, Grundke-Iqbal I, Damuni Z, Iqbal K: Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and -2C and its implication in Alzheimer disease. FEBS Lett 1994;1:94-98.
15. Gong CX, Grundke-Iqbal I, Iqbal K: Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A. Neuroscience 1994;4:765-772.
16. Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K: Alzheimer's disease abnormally phosphorylated tau is dephosphorylated by protein phosphatase-2B (calcineurin). J Neurochem 1994;62:803-806.
17. Cohen PT: Protein phosphatase 1 - Targeted in many directions. J Cell Sci 2002;115:241-256.
18. Lin JW, Wyszynski M, Madhavan R, Sealock R, Kim JU, Sheng M: Yotiao, a novel protein of neuromuscular junction and brain that interacts with specific splice variants of NMDA receptor subunit NR1. J Neurosci 1998;6:2017-2027.
19. McMillan LB: Brain actin-associated protein phosphatase 1 holoenzymes containing spinophilin, neurabin, and selected catalytic subunit isoforms. J Biol Chem 1999;274:35845-35854.
20. Huang FL, Glinsmann WH: Interaction of rabbit muscle phosphorylase phosphatase by cAMP-dependent protein kinase. Proc Natl Acad Sci USA 1975;72:3004-3008.
21. Walaas SI, Aswad DW, Grengard P: A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature 1983;301:69-71.
22. Oliver CJ, Terry-Lorenzo RT, Elliott E, Bloomer WA, Li S, Brautigan DL, Colbran RJ, Shenolikar S: Targeting protein phosphatase 1 (PP1) to the actin cytoskeleton: The neurabin I/PP1 complex regulates cell morphology. Mol Cell Biol 2002;13:4690-4701.
23. McAvoy T: Regulation of neurabin 1 interaction with protein phosphatase 1 by phosphorylation. Biochemistry 1999;38:12943-12949.
24. Janssens V, Goris J: Protein phosphatase 2A: A highly regulated family of serine/threonine phosphatases implicated in cell growth and signaling. Biochem J 2001;353:417-439.
25. Fai CS, Nikolaus JS: An NMDA receptor signaling complex with protein phosphatase 2A. J Neurosci 2001;20:7985-7992.
26. Li M, Makkinje A, Damuni Z: The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A. J Biol Chem 1996;19:11059-11062.
27. Klee CB, Ren H, Wang XD: Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem 1998;22:13367-13370.
28. Rusnak F, Mertz P: Calcineurin: Form and function. Physiol Rev 2000;4:1483-1521.
29. Halpain S, Hipolito A, Saffer L: Regulation of F-actin stability in dendritic spines by glutamate receptors and calcineurin. J Neurosci 1998;18:9835-9844.
30. 2+ signaling pathway in GABAergic neurons of the hippocampus. Proc Natl Acad Sci USA 1998;95:3245-3250.
31. Steiner JP: High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature 1992;358:584-587.
32. Lai MM, Burnett PE, Wolosker H, Blackshaw S, Snyder SH: Cain, a novel physiologic protein inhibitor of calcineurin. J Biol Chem 1998;273:18325-18331.
33. Coghlan VM: Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 1995;267:108-111.
34. Iqbal K, Grundke-Iqbal I, Smith AJ, George L, Tung Y-C, Zaidi T: Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. Proc Natl Acad Sci USA 1989;86:5646-5650.
35. Lee MY, Balin BJ, Otvos L, Trojanowski JQ: A68:A major subunit of paired helical filaments and derivatized forms of normal tau. Science 1991;251:675-678.
36. Goedert M, Spillantini MG, Cairns NJ, Crowther RA: Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron 1992;8:159-168.
37. Grundke-Iqbal I, Iqbal K: Tau pathology generated by overexpression of tau. Am J Pathol 1999;155:1781-1785.
38. Hu YY, He SS, Wang XC, Duan QH, Grundke-Iqbal I, Iqbal K, Wang JZ: Level of nonphosphorylated tau in CSF of Alzheimer disease: An ultrasensitive bienzyme-substrate-recycle ELISA. Am J Pathol 2002;4:1269-1278.
39. Khatoon S, Grundke-Iqbal I, Iqbal K: Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains. FEBS Lett 1994;1:80-84.
40. Vogelsberg-Ragaglia V, Schuck T, Trojanowski JQ, Lee VM: PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp Neurol 2001;168:402-412.
41. Saito T, Ishiguro K, Uchida T, Miyamoto E, Kishimoto T, Hisanaga S: In situ dephosphorylation of tau by protein phosphatase 2A and 2B in fetal rat primary cultured neurons. FEBS Lett 1995;376:238-242.
42. Kim D, Su J, Cotman CW: Sequence of neurodegeneration and accumulation of phosphorylated tau in cultured neurons after okadaic acid treatment. Brain Res 1999;839:253-262.
43. Tanaka T, Zhong J, Iqbal K, Trenkner E, Grundke-Iqbal I: The regulation of phosphorylation of tau in SY5Y neuroblastoma cells: The role of protein phosphatases. FEBS Lett 1998;426:248-254.
44. Sontag E, Nunbhakdi-Craig V, Lee G, Bloom GS, Mumby MC: Regulation of the phosphorylation state and microtubule-binding activity of tau by protein phosphatase 2A. Neuron 1996;6:1201-1207.
45. Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K: Inhibition of PP-2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262/356. FEBS Lett 2001;1-2:15-22.
46. Gong C-X, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, Iqbal K: Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem 2000;275:5535-5544.
47. Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K: Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS Lett 2000;1:87-93.
48. Lee J, Hong H, Im J, Byun H, Kim D: The formation of PHF-1 and SMI-31 positive dystrophic neurites in rat hippocampus following acute injection of okadaic acid. Neurosci Lett 2000;282:49-52.
49. Sun L, Liu SY, Wang JZ: Inhibition of PP2A and PP1 induced tau hyperphosphorylation and impairment of spatial memory retention in rats. Neuroscience, in press.
50. Planel E, Yasutake K, Fujita SC, Ishiguro K: Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3beta and cyclin-dependent kinase 5 inhibition and results in Tau hyperphosphorylation in the hippocampus of starved mouse. J Biol Chem 2001;276:34298-34306.
51. Kins S, Crameri A, Evans DR, Hemmings BA, Nitsch RM, Götz J: Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice. J Biol Chem 2001;41:38193-38200.
52. Gotz J, Probst A, Ehler E, Hemmings B, Kues W: Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. Proc Natl Acad Sci USA 1998;21:12370-12375.
53. Janssens V, Goris J: Protein phosphatase 2A: A highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 2001;3:417-439.
54. Sontag E, Nunbhakdi-Craig V, Lee G, Brandt R, Kamibayashi C, Kuret J, WhiteIII CL, Mumby MC, Bloom GS: Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies. J Biol Chem 1999;36:25490-25498.
55. Sontag E, Nunbhakdi-Craig V, Lee G, Bloom GS, Mumby MC: Regulation of the phosphorylation state and microtubule-binding activity of tau by protein phosphatase 2A. Neuron 1996;17:1201-1207.
56. Kamibayashi C, Estes R, Lickteig RL, Yang SI, Craft C, Mumby MC: Comparison of heterotrimeric protein phosphatase 2A containing different B subunits. J Biol Chem 1994;269:20139-20148.
57. Mandelkow E-M, Biernat J, Drewes G, Gustke N, Trinczek B, Mandelkow E: Tau domains, phosphorylation, and interactions with microtubules. Neurobiol Aging 1995;16:355-363.
58. Goode BL, Denis PE, Panda D, Radeke MJ, Miller HP, Wilson L, Feinstein SC: Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly. Mol Biol Cell 1997;8:353-365.
59. Gustke N, Trinczek B, Biernat J, Mandelkow E-M, Mandelkow E: Domains of tau protein and interactions with microtubules. Biochemistry 1994;33:9511-9522.
60. Liao H, Li Y, Brautigan DL, Gundersen GG: Protein phosphatase 1 is targeted to microtubules by the microtubule-associated protein tau. J Biol Chem 1998;34:21901-21908.
61. Wei Q, Holzer M, Brueckner MK, Liu Y, Arendt T: Dephosphorylation of tau protein by calcineurin triturated into neural living cells. Cell Mol Neurobiol 2002;1:13-24.
62. Garver TD, Kincaid RL, Conn RA, Billingsley ML: Reduction of calcineurin activity in brain by antisense oligonucleotides leads to persistent phosphorylation of tau; protein at Thr181 and Thr231. Mol Pharmacol 1999;4:632-641.
63. Wang QB, Wang JZ: Injection of bradykinin or cyclosporine A to hippocampus induces Alzheimer-like phosphorylation of tau and abnormal behavior in rats. Chin Med J 2002;6:884-887.
64. Kayyali US, Zhang W, Yee AG, Seidman J, Potter H: Cytoskeletal changes in the brains of mice lacking calcineurin A alpha. J Neurochem 1997;68:1668-1678.
65. Gong CX, Shaikh S, Grundke-Iqbal I, Iqbal K: Inhibition of protein phosphatase-2B (calcineurin) activity towards Alzheimer abnormally phosphorylated tau by neuroleptics. Brain Res 1996;1-2:95-102.
66. Gong CX, Wegiel J, Lidsky T, Zuck L, Avila J, Wisniewski HM, Grundke-Iqbal I, Iqbal K: Regulation of phosphorylation of neuronal microtubule-associated proteins MAP1b and MAP2 by protein phosphatase-2A and -2B in rat brain. Brain Res 2000;2:299-309.
67. Hirokawa N, Hisanaga S, Shiomura Y: MAP2 is a component of crossbridges between microtubules and neurofilaments in the neuronal cytoskeleton: Quick-freeze, deep-etch immunoelectron microscopy and reconstitution studies. J Neurosci 1988;8:2769-2779.
68. Leterrier JF, Rusakov DA, Nelson BD, Linden M: Interactions between brain mitochondria and cytoskeleton: Evidence for specialized outer membrane domains involved in the association of cytoskeleton-associated proteins to mitochondria in situ and in vitro. Microsc Res Tech 1994;3:233-261.
69. Hoffman PN: Distinct roles of neurofilament and tubulin gene expression in axonal growth. Ciba Found Symp 1988;138:192-204.
70. Yabe JT, Pimenta A, Shea TB: Kinesin-mediated transport of neurofilament protein oligomers in growing axons. J Cell Sci 1999;21:3799-3814.
71. Jung C, Yabe JT, Shea TB: C-terminal phosphorylation of the high molecular weight neurofilament subunit correlates with decreased neurofilament axonal transport velocity. Brain Res 2000;1-2:12-19.
72. Jung C, Yabe JT, Lee S, Shea TB: Hypophosphorylated neurofilament subunits undergo axonal transport more rapidly than more extensively phosphorylated subunits in situ. Cell Motil Cytoskeleton 2000;2:120-129.
73. Yabe JT, Jung C, Chan WK, Shea TB: Phospho-dependent association of neurofilament proteins with kinesin in situ. Cell Motil Cytoskeleton 2000;4:249-262.
74. Schimidt ML, Martin JA, Lee VMY, Trojanowski JQ: Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders. Acta Neuropathol 1996;91:475-481.
75. Hu YY, He SS, Wang XC, Duan QH, Khatoon S, Grundke-Iqbal I, Iqbal K, Wang JZ: Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients. Neurosci Lett 2002;3:156-160.
76. Saito T, Shima H, Osawa Y, Nagao M, Hemmings BA, Kishimoto T, Hisanaga S: Neurofilament-associated protein phosphatase 2A: Its possible role in preserving neurofilaments in filamentous states. Biochemistry 1995;22:7376-7384.
77. Terry-Lorenzo RT, Inoue M, Connor JH, Haystead TA, Armbruster BN, Gupta RP, Oliver CJ, Shenolikar S: Neurofilament-L is a protein phosphatase-1-binding protein associated with neuronal plasma membrane and post-synaptic density. J Biol Chem 2000;4:2439-2446.
78. Strack S, Westphal RS, Colbran RJ, Ebner FF, Wadzinski BE: Protein serine/threonine phosphatase 1 and 2A associate with and dephosphorylate neurofilaments. Mol Brain Res 1997;1-2:15-28.
79. Wang JZ, Tung YC, Wang Y, Li XT, Iqbal K, Grundke-Iqbal I: Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells. FEBS Lett 2001;507:81-87.
80. Veeranna, Shetty KT, Link WT, Jaffe H, Wang J, Pant HC: Neuronal cyclin-dependent kinase-5 phosphorylation sites in neurofilament protein (NF-H) are dephosphorylated by protein phosphatase 2A. J Neurochem 1995;6:2681-2690.
81. Skovronsky DM, Moore DB, Milla ME, Doms RW, Lee VMY: Protein kinase C-dependent α-secretase competes with β-secretase for cleavage of amyloid-β precursor protein in the trans-Golgi network. J Biol Chem 2000;4:2568-2575.
82. Greenfield JP, Leung LW, Cai DM, Kaasik K, Gross RS, Rodriguez-Boulan E, Greengard P, Xu HX: Estrogen lowers Alzheimer β-amyloid generation by stimulating trans-Golgi network vesicle biogenesis. J Biol Chem 2002;14:12128-12136.
83. Gandy S, Greengard P: Regulated cleavage of the Alzheimer amyloid precursor protein: Molecular and cellular basis. Biochimie 1994;76/3-4:300-303.
84. da Cruz e Silva EF, da Cruz e Silva OA, Zaia CT, Greengard P: Inhibition of protein phosphatase 1 stimulates secretion of Alzheimer amyloid precursor protein. Mol Med 1995;1:535-541.
85. Caporaso GL, Gandy SE, Buxbaum JD, Ramabhadran TV, Greengard P: Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein. Proc Natl Acad Sci USA 1992;89:3055-3059.
86. Molloy SS, Thomas L, Kamibayashi C, Mumby MC, Thomas G: Regulation of endosome sorting by a specific PP2A isoform. J Cell Biol 1998;142:1399-1411.
87. Reilein A, Tint IS, Peunova NI, Enikolopov GN, Gelfand VI: Regulation of organelle movement in melanophores by protein kinase A (PKA), protein kinase C (PKC), and protein phosphatase 2A (PP2A). J Cell Biol 1998;142:803-813.
88. Horn M, Banting G: Okadaic acid treatment leads to a fragmentation of the trans-Golgi network and an increase in expression of TGN38 at the cell surface. Biochem J 1994;301:69-73.
89. Slepnev VI, Ochoa GC, Butler MH, Grabs D, Camilli PD: Role of phosphorylation of the assembly of endocytic coat complexes. Science 1998;281:821-824.
90. Krauthein A, Rustenbeck I, Steinfelder HJ: Phosphatase inhibitors induce defective hormone secretion in insulin-secreting cells and entry into apoptosis. Exp Clin Endocrinol Diabetes 1999;107:29-34.
91. Molloy SS, Anderson ED, Jean F, Thomas G: Bi-cycling the furin pathway: From TGN location to pathogen activation and embryogenesis. Trends Cell Biol 1999;9:28-35.
92. Varlamov O, Kalinina E, Chen F, Fricker L: Protein phosphatase 2A binds to the cytoplasmic tail of carboxypeptidase D and regulate post-trans-Golgi network trafficking. J Cell Sci 2000;114:311-322.
93. Lowe M, Gonatas NK, Warren G: The mitotic phosphorylation cycle of the cis-Golgi matrix protein GM130. J Cell Biol 2000;149:341-356.
94. Price NE, Munby MC: Brain protein serine/threonine phosphatases. Curr Opin Neurobiol 1999;9:336-342.
95. Bigio EH, Hynan LS, Sontag E, Satumtira S, White CL: Synapse loss is greater in presenile than senile onset Alzheimer disease: Implications for the cognitive reserve hypothesis. Neuropathol Appl Neurobiol 2002;3:218-227.
96. Winder DG, Sweatt JD: Roles of serine/threonine phosphatases in hippocampal synaptic plasticity. Nat Rev Neurosci 2001;2:461-474.